Bispecific therapies require clearer terminology to improve safety and communication.
Ginger Blackmon, PharmD
Advertisement
Articles by Ginger Blackmon, PharmD
Ginger Blackmon, PharmD, explains how NCODA’s Positive Quality Interventions (PQIs) help improve oncology care by guiding best practices, supporting teamwork, and streamlining workflows.
Advertisement
Latest Updated Articles
The Term 'Bispecific Antibody' Is No Longer EnoughJune 16th 2025
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
2
Menin Inhibitors in AML: Frequently Asked Questions
3
FDA Approves Veligrotug-vvze as First Agent With Data in Both Active and Chronic Thyroid Eye Disease
4
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS
5